These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28971365)

  • 1. Investigating Oral Absorption of Carbamazepine in Pediatric Populations.
    Kohlmann P; Stillhart C; Kuentz M; Parrott N
    AAPS J; 2017 Nov; 19(6):1864-1877. PubMed ID: 28971365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Biopharmaceutical Performance of Supersaturating Formulations of Carbamazepine in Rats Using Physiologically Based Pharmacokinetic Modeling.
    Thakore SD; Thakur PS; Shete G; Gangwal R; Narang AS; Sangamwar AT; Bansal AK
    AAPS PharmSciTech; 2019 Apr; 20(5):179. PubMed ID: 31041552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.
    Villiger A; Stillhart C; Parrott N; Kuentz M
    AAPS J; 2016 Jul; 18(4):933-47. PubMed ID: 27060007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
    Pawar G; Wu F; Zhao L; Fang L; Burckart GJ; Feng K; Mousa YM; Al Shoyaib A; Jones MC; Batchelor HK
    AAPS J; 2023 Jun; 25(4):67. PubMed ID: 37386339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Critical Variables of Azithromycin Oral Absorption Using In Vitro Tests and PBPK Modeling.
    Guimarães M; Somville P; Vertzoni M; Fotaki N
    J Pharm Sci; 2021 Dec; 110(12):3874-3888. PubMed ID: 34530004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.
    Liu XI; van den Anker JN; Burckart GJ; Dallmann A
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S94-S107. PubMed ID: 34185902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Evaluation of Montelukast Pediatric Formulations: Part II - a PBPK Modelling Approach.
    Guimarães M; Vertzoni M; Fotaki N
    AAPS J; 2022 Jan; 24(1):27. PubMed ID: 35013803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and applications of a physiologically-based model of paediatric oral drug absorption.
    Johnson TN; Bonner JJ; Tucker GT; Turner DB; Jamei M
    Eur J Pharm Sci; 2018 Mar; 115():57-67. PubMed ID: 29309876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Affecting Successful Extrapolation of Ibuprofen Exposure from Adults to Pediatric Populations After Oral Administration of a Pediatric Aqueous Suspension.
    Statelova M; Holm R; Fotaki N; Reppas C; Vertzoni M
    AAPS J; 2020 Nov; 22(6):146. PubMed ID: 33184711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
    Kaur N; Narang A; Bansal AK
    Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
    Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
    Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Oral Absorption of Irbesartan Using Biorelevant Dissolution Testing and PBPK Modeling.
    Kaur N; Thakur PS; Shete G; Gangwal R; Sangamwar AT; Bansal AK
    AAPS PharmSciTech; 2020 Mar; 21(3):102. PubMed ID: 32152915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.
    Kovacević I; Parojcić J; Homsek I; Tubić-Grozdanis M; Langguth P
    Mol Pharm; 2009; 6(1):40-7. PubMed ID: 19248231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring in vitro solubility of lamotrigine in physiologically mimetic conditions to prospect the in vivo dissolution in pediatric population.
    Caleffi-Marchesini ER; Borghi-Pangoni FB; Macente J; Chiamulera-Mantovani P; Mazucheli J; Cristofoletti R; Diniz A
    Biopharm Drug Dispos; 2023 Apr; 44(2):147-156. PubMed ID: 36951570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.